News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
153
Sources here
18
Companies here
8
Search results Stored financial headlines

Active search

153 matching headlines

Ticker or company: CORAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cencora stock holds after fiscal 2026 growth update

Cencora's stock movement in fiscal 2026 is driven by its financial performance, with investor focus on revenue, operating profit, and earnings per share given the company's low-margin, high-volume service model. Margin discipline and management guidance are crucial metrics for assessing the value conversion of …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora stock trades steadily as recent earnings highlight solid revenue growth

Cencora Inc. (NYSE: COR) reported robust revenue growth, reaching approximately $68.0 billion, up from $63.0 billion year-over-year, alongside an increase in adjusted EPS from $3.50 to $3.90. The healthcare distributor's steady performance is supported by strong free cash flow, consistent dividend payments, and strategic …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

XS3071246378 Bond Profile — Key Metrics

This article provides the key metrics for the Cencora, Inc. 3.625% 22-MAY-2032 bond, identified by XS3071246378, traded on the Stuttgart Stock Exchange. It details the issuer's profile as a pharmaceutical sourcing and distribution services company operating through U.S. and International Healthcare Solutions segments. Key …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora stock trades steadily as specialty distribution growth supports earnings

Cencora Inc. shows stable performance within the US healthcare distribution sector, reporting revenue growth and solid adjusted earnings due to sustained demand for specialty pharmaceuticals. The company's fiscal Q2 2024 results indicate increased revenue, adjusted diluted EPS growth, and positive guidance for the full …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A1ZW87 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the A1ZW87 bond issued by Cencora, Inc., which has a coupon rate of 4.25% and matures on March 1, 2045. It details the bond's interest payment overview, including the current coupon rate and the next scheduled payment …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora stock reflects steady healthcare distribution role as investors track U.S. drug spending tre

Cencora Inc. plays a crucial role in the U.S. pharmaceutical supply chain as one of the largest distributors of drugs to healthcare providers. The company's business model is characterized by high volumes, tight logistics, and thin per-unit margins, making efficiency paramount. Investors monitor Cencora's …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Cencora’s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors

Cencora (COR) recently reported past-quarter revenues of US$78.36 billion, a 3.8% year-on-year increase, but this figure was 3.9% below analyst expectations. This revenue miss, despite overall growth, indicates potential challenges from ongoing margin pressures and evolving reimbursement frameworks, highlighting the importance of Cencora's investments …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context